References
- Aantaa E, Skinhoj A. Controlled clinical trial comparing the effect of betahistine hydrochloride and prochlorperazine maleate on patients with Meniere's disease. Ann Clin Res 1976; 8: 284–7
- Dauman R, Charlet de Sauvage R. Continuous monitoring of SP and CAP during glycerol test in Meniere's disease: preliminary results. Rev Laryngol Otol Rhiuol (Bordeaux) 1984; 105: 219–21
- Eggermont J J. Narrow-band AP latencies in normal and recruiting human ears. J Acoust Soc Am 1979; 65: 463–70
- Eggermont J J, Odenthal D W. Frequency selective masking in electrocochleography. Rev Laryngol Otol Rhinol (Bordeaux) 1974; 95: 489–96
- Elberling C. Action potentials along the cochlear partition recorded from the ear canal in man. Scand Audiol 1974; 3: 13–9
- Grew I JC, Menon G N. Betahistine hydrochloride in Ménière's disease. Postgrad Med J 1976; 52: 501–3
- Jakobs P, Martin G. Die Therapie des Tinnitus nach knall-traumatischer Schadigung. HNO 1978; 26: 104–6
- Lutman M E, Wood E J. A simple clinical measure of frequency resolution. Br J Audiol 1985; 19: 1–8
- Morrison A W, Moffat D A, O'Connor A F. Clinical usefulness of electrocochleography in Meniere's disease: An analysis of dehydrating agents. Otol Clin North Am 1980; 13: 703–21
- Parker D J, Thornton A RD. Cochlear travelling wave velocities calculated from the derived components of the cochlear nerve and brainstem evoked responses of the human auditory system. Scand Audiol 1978a; 7: 67–70
- Parker D J, Thornton A RD. The validity of the derived cochlear nerve and brainstem evoked responses of the human auditory system. Scand Audiol 1978b; 7: 45–52
- Wilmot T J. Meniere's disorder. Clin Otol Allied Sci 1979; 4: 131–43
- Zerlin S. Travelling wave velocity in the human cochlea. J Acoust Soc Am 1969; 46: 1011–5